GCCA: Cement and Concrete Industry Scales Up Carbon Capture, Utilisation and Storage (CCUS) Efforts to Accelerate Decarbonisation
The Clean Energy Ministerial CCUS (CEM CCUS) and the Global Cement and Concrete Association (GCCA) have today, at the first-ever Global Clean Energy Action Forum (GCEAF), announced an agreement that will help scale up the deployment of carbon capture, utilisation and storage (CCUS) throughout the cement and concrete industry, in a move to stimulate innovation, investment and increase the pace of decarbonisation efforts.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220923005359/en/
Major CCUS industry and government collaboration announced at Global Clean Energy Action Forum (GCEAF) in Pittsburgh, USA. Left to right: Thomas Guillot, CEO of the Global Cement and Concrete Association, Henriette Nesheim, Assistant Director General, Norwegian Ministry of Petroleum and Energy – and CEM CCUS Initiative Co-Lead from Norway, Brad Crabtree, Assistant Secretary, Fossil Energy and Carbon Management, US Department of Energy (Photo: Business Wire)
Central to the agreement will be exploring incentives, policy frameworks and finance solutions at a global level that can enable industrial-scale CCUS projects over the next ten years. The two organisations will work together to ensure the long-term deployment of CCUS, beyond 2030, via both policy and technological development.
The agreement sets out the role CCUS can have in safely and effectively delivering a net zero future and facilitates the identification and mapping of potential cement-sector CCUS projects. It will explore the transport and storage infrastructure needs involved in integrating cement CCUS projects into strategic CCUS transport and storage hubs. It will also help to foster project partnerships and lead to acceleration of projects in developing economies.
Thomas Guillot, CEO of the Global Cement and Concrete Association, said: “Cement is the vital ingredient in concrete, the world’s most-used human-made material. It is the backbone of the modern world. The industry is striving to innovate at every stage of the concrete life cycle. We see carbon capture as a vital lever for the global cement industry to achieve its ambitious goal of net-zero concrete by 2050.
“We are starting to see the first CCUS projects already emerge. We have mapped 35 projects announced and underway across the world and up to 100 additional projects are also in the pipeline among our member companies who operate all around the globe.”
Mr Guillot added: “This is good progress, but we cannot achieve our decarbonisation mission alone. CCUS is a key enabling technology, and it is a critical area for collaboration to ensure that government policy, enabling infrastructure and wider investment is in place. That is why the partnership with the Clean Energy Ministerial CCUS Initiative is so important, to help unlock and accelerate further progress and deployment.”
Henriette Nesheim, Assistant Director General, Norwegian Ministry of Petroleum and Energy – and CEM CCUS Initiative Co-Lead from Norway, said: “This is a great opportunity to work together with a vitally important industry. In Norway we are already building our first cement-CCS project in Brevik, and we look forward to sharing the experience with others.”
Brad Crabtree, Assistant Secretary, Fossil Energy and Carbon Management, US Department of Energy, said: “Reaching our ambitious climate goals requires the decarbonization of various heavy industries, including cement production. In the United States, through the support of Congress, we are currently funding projects to develop carbon capture technologies in cement and other key industrial sectors that are essential to modern life, with the aim of helping to achieve net-zero emissions economywide by 2050 and retaining and creating high-wage industrial jobs. The U.S. Government is keen to drive progress in this area, together with our partners in the CEM CCUS Initiative and the Global Cement and Concrete Association.”
To reach these objectives, both parties have agreed to the organisation of expert workshops, inclusive of CEM CCUS and GCCA members, as well as relevant stakeholders and partners including the CEM Industry Deep Decarbonisation Initiative (IDDI). Both parties will also produce joint reports and organise public events outlining progress in opportunities to implement CCUS projects at strategic hubs.
The agreement was announced at a GCCA and CEM CCUS led event at the Global Energy Action Forum, focused on the challenge and opportunity for CCUS as a major decarbonisation lever for the global cement and concrete sector. This aligns with a core pillar of the GCCA’s 2050 Net Zero Roadmap, launched last year, in which its members have committed to the deployment of at least ten industrial-scale CCUS projects by 2030.
At the event, the industry summarised the key challenges in accelerating the deployment of CCUS and outlined the enabling factors crucial to increasing its rollout to create a greener concrete future. These factors include supporting policies and financing, public procurement progress and CO2 infrastructure and storage options alongside strategic hubs.
-ends-
Notes to editors:
Speakers at the GCCA and CEM CCUS led event at the Global Energy Action Forum included:
- Henriette Nesheim, Assistant Director General, Norwegian Ministry of Petroleum and Energy – and CEM CCUS Initiative Co-Lead from Norway
- Dan Dorner, Head of CEM Secretariat
- Thomas Guillot, CEO, Global Cement and Concrete Association
Panel:
- Chris Ward, CEO, Lehigh Hanson Cement
- Bjorn Otto Sverdrup, ExCom Chair, OGCI
- Tareq Emtairah, Director, UNIDO
- Brad Crabtree, Assistant Secretary, Fossil Energy and Carbon Management, US Department of Energy
- Khalid Abuleif, Chief Climate Negotiator, Saudi Arabia
- Moderator: Juho Lipponen, CEM CCUS
About the GCCA
Launched in January 2018, the Global Cement and Concrete Association (GCCA) is dedicated to developing and strengthening the sector’s contribution to sustainable construction. The GCCA aims to foster innovation throughout the construction value chain in collaboration with industry associations as well as architects, engineers, and innovators. The association demonstrates how concrete solutions can meet global construction challenges and sustainable development goals while showcasing responsible industrial leadership in the manufacture and use of cement and concrete. It complements and supports the work of associations at national and regional levels.
About CEM CCUS
The Clean Energy Ministerial CCUS Initiative is a group of 14 member countries who have joined forces to accelerate CCUS together. The CEM CCUS countries all develop comprehensive CCUS programmes, with the intent to decarbonise all relevant industrial sectors. The objective of the Initiative is to accelerate CCUS as a viable CO2 mitigation option, facilitate diffusions of knowledge on technologies, regulations, and policies, and lead to strategic partnerships to accelerate both near- and longer-term investment in CCUS. As an action-orientate platform, the Imitative does not perform analysis, but serves to bring government, industry and the financial and investment sectors together.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220923005359/en/
Contact information
Media enquiries should be directed to:
GCCA@BCW-global.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 11:00:00 EET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 11:00:00 EET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 11:00:00 EET | Press release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 10:00:00 EET | Press release
Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 09:44:00 EET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
